Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells

Authors:
  • JLJi Young Lee
    Ji Young Lee
  • HKHyo Jeong Kim
    Hyo Jeong Kim
  • NYNal Ae Yoon
    Nal Ae Yoon
  • WLWon Hyeok Lee
    Won Hyeok Lee
  • YMYoung Joo Min
    Young Joo Min
  • BKByung Kyun Ko
    Byung Kyun Ko
  • BLByung Ju Lee
    Byung Ju Lee
  • ALAran Lee
    Aran Lee
  • HCHee Jeong Cha
    Hee Jeong Cha

Abstract
Tristetraprolin (TTP) and let-7 microRNA exhibit suppressive effects on cell growth through down-regulation of oncogenes. Both TTP and let-7 are often repressed in human cancers, thereby promoting oncogenesis by derepressing their target genes. However, the precise mechanism of this repression is unknown. We here demonstrate that p53 stimulated by the DNA-damaging agent doxorubicin (DOX) induced the expression of TTP in cancer cells. TTP in turn increased let-7 levels through down-regulation of Lin28a . Correspondingly, cancer cells with mutations or inhibition of p53 failed to induce the expression of both TTP and let-7 on treatment with DOX. Down-regulation of TTP by small interfering RNAs attenuated the inhibitory effect of DOX on let-7 expression and cell growth. Therefore, TTP provides an important link between p53 activation induced by DNA damage and let-7 biogenesis. These novel findings provide a mechanism for the widespread decrease in TTP and let-7 and chemoresistance observed in human cancers.

This publication has 42 references indexed in Scilit: